MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Glycosylated proteins account for a majority of the post-translation modifications of cell surface, secreted and circulating proteins. Within the tumor microenvironment, the presence of immune cells, extracellular matrix proteins, cell surface receptors and interactions between stroma and tumor cells are all processes mediated by glycan binding and recognition reactions. Changes in glycosylation during tumorigenesis are well documented to occur, and affect all of these associated adhesion and regulatory functions. A MALDI imaging mass spectrometry (MALDI-IMS) workflow for profiling N-linked glycan distributions in fresh/frozen tissues and formalin-fixed paraffin-embedded (FFPE) tissues has recently been developed. The key to the approach is the application of a molecular coating of peptide-N-glycosidase to tissues, an enzyme that cleaves asparagine-linked glycans from their protein carrier. The released N-linked glycans can then be analyzed by MALDI-IMS directly on tissue. Generally 40 or more individual glycan structures are routinely detected, and when combined with histopathology localizations, tumor specific glycans are readily grouped relative to non-tumor regions and other structural features. This technique is a recent development and new approach in glycobiology and mass spectrometry imaging research methodology, thus potential uses such as tumor-specific glycan biomarker panels and other applications are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635 · cited 2×
“Function and types of glycosylation The functions and regulation of glycoproteins carrying N-linked and O-linked sugar chains have been extensively reviewed [Moremen, Tiemeyer, & Nairn, 2012; Varki 2016; Kudelka, Adv Cancer Res.”
BackgroundCell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Taniguchi (2015) · doi:10.1016/bs.acr.2014.11.001 · Cited by 381 · cited 4×
“This is consistent with the activity of GnT-III, the glycosyltransferase responsible for catalyzing the addition of the bisecting GlcNAc, being primarily associated with expression reflecting an anti-tumorigenesis activity [Taniguchi & Kizuka, 2015].”
BackgroundMethodInfluential
Cited by
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
The tumour glyco-code as a novel immune checkpoint for immunotherapy
RodrÍguez, E., Schetters, S. T. T., & van Kooyk, Y. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2018.3 · Cited by 473
Mass spectrometry approaches to glycomic and glycoproteomic analyses
Ruhaak, L. R., Xu, G., Li, Q., Goonatilleke, E., & Lebrilla, C. B. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00732 · Cited by 395
Metadata
- Venue
- Advances in Cancer Research
- Publisher
- Elsevier
- Published
- 2017
- Volume
- 134
- Pages
- 85-116
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W2560973744
- Cited by
- 148
- References
- 3
- FWCI
- 14.46
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues. https://app.cochat.ai/papers/10.1016/bs.acr.2016.11.009
- The paper
- MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues. (2017). Advances in Cancer Research. https://doi.org/10.1016/bs.acr.2016.11.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.